Frequency News and Research

RSS

Variations of MYH9 gene help explain high rate of kidney disease in African Americans

Several recent studies have suggested that common gene variations may be responsible for much of the elevated risk of kidney disease in African Americans.

8 Nov 2008

21 million Americans suffers arthritis pain

Approximately 21 million Americans - 9.5 percent of adults 18 and older - either visited or called a doctor for a prescription to reduce arthritis pain in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

6 Nov 2008

Safety and efficacy of febuxostat for gout examined

The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.

5 Nov 2008

Women have a greater diversity of microbes on their palms than men

A new University of Colorado at Boulder study indicates that not only do human hands harbor far higher numbers of bacteria species than previously believed, women have a significantly greater diversity of microbes on their palms than men.

4 Nov 2008

Urgent need for research into medication overuse headaches

There is a critical need to review current treatment strategies for the increasingly common problem of medication overuse headaches (MOH), according to a series of international papers in the November issue of Cephalalgia.

4 Nov 2008

Watching lots of sexual content on TV linked to subsequent teen pregnancy

Adolescents who have high levels of exposure to television programs that contain sexual content are twice as likely to be involved in a pregnancy over the following three years as their peers who watch few such shows, according to a new RAND Corporation study.

4 Nov 2008

Smaller mosquitoes more likely to be infected with viruses that cause diseases in humans

An entomologist at the Illinois Natural History Survey, a division of the new UI Institute for Natural Resource Sustainability, says smaller mosquitoes are more likely to be infected with viruses that cause diseases in humans.

4 Nov 2008

Post-traumatic stress disorder symptoms linked to increased risk of death after heart events

Individuals who receive implantable cardiac defibrillators after a sudden heart event appear more likely to die within five years if they experience symptoms of post-traumatic stress disorder, regardless of the severity of their disease, according to a report in the November issue of Archives of General Psychiatry.

4 Nov 2008

Bladder conditions - raising awareness

November is Bladder Health Month, and there's no better time to raise awareness of the bladder conditions that affect millions of patients, who often suffer in silence with common, treatable symptoms.

4 Nov 2008

Pfizer's Toviaz (fesoterodine fumarate) receives FDA approval for the treatment of overactive bladder

Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.

2 Nov 2008

Frequent urination protects against bladder cancer

A new study has analysed the effect of urinary frequency on the risk of bladder cancer. The conditions of this research which is published in the latest number of the International Journal of Cancer, show a direct association between the number of times people get up at night to urinate and protection against bladder cancer.

30 Oct 2008

Pulsed ultrasound used to remote control brain circuits

In a twist on nontraditional uses of ultrasound, a group of neuroscientists at Arizona State University has developed pulsed ultrasound techniques that can remotely stimulate brain circuit activity.

29 Oct 2008

Eye pressure spikes and glaucoma

A new Australian study has found some surprising factors which contribute to glaucoma and other pressure-related eye diseases.

29 Oct 2008

Link found between brain receptors and schizophrenia

Scientists at Newcastle University in the UK have revealed a link between schizophrenia and a lack of specific brain receptors.

28 Oct 2008

Nanocort demonstrates safety and good response in phase I/II trial for rheumatoid arthritis

Galapagos NV has announced that Nanocort has demonstrated safety as well as a faster and more pronounced decrease in rheumatoid arthritis disease symptoms compared to reference medication.

27 Oct 2008

Lack of brain NMDA receptors linked to schizophrenia

A lack of specific brain receptors has been linked with schizophrenia in new research by scientists at Newcastle University.

27 Oct 2008

Sensitive ultrasound to spot early-stage cancer

European researchers have developed highly sensitive ultrasound equipment that can detect tiny quantities of reflective microbubbles engineered to stick to specific tumour cells. The technique should pick up tumours early and improve patients' chances of survival.

26 Oct 2008

NanoVibronix receives FDA clearance for PainShield diathermy device

NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.

23 Oct 2008

Educational literature can influence young women's use of indoor tanning

A new study indicates that educational literature can influence young women's use of indoor tanning, not by raising their fear of skin cancer but by changing their attitudes about indoor tanning and promoting healthier alternatives for changing appearance.

23 Oct 2008

FDA approves new labeling for psoriasis drug Raptiva

The U.S. Food and Drug Administration today announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including progressive multifocal leukoencephalopathy (PML), with the use of Raptiva (efalizumab). The labeling changes are based on the FDA's post-market surveillance.

19 Oct 2008